“Levetiracetam Plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children With Epilepsy”. 2023. Brazilian Journal of Pharmaceutical Sciences 59 (May): e21414. https://doi.org/10.1590/s2175-97902023e21414.